Active NIH Grants
NIH/NINDS, 2R01NS100947, 12/08/2023 – 11/30/2028
Inflammatory regulation of epileptogenesis after status epilepticus
PI: Jianxiong Jiang (25% effort)
NIH/NINDS, R61(R33)NS130199, 08/15/2023 – 07/31/2026
EP2 Antagonists for Ischemic Stroke
Contact PI: Jianxiong Jiang (15% effort); MPI: Jiawang Liu
NIH/NINDS, R61(R33)NS124923, 12/01/2021 – 11/30/2024
Targeting TRPC3 Channels for Epileptic Seizures
Contact PI: Jianxiong Jiang (15% effort); MPI: Wei Li
NIH/NINDS, STTR (Phase I), R41NS135658, 09/20/2023 – 08/31/2024
Developing a selective TRPC3 ion channel inhibitor for epilepsy treatment
Institution Partner: Jianxiong Jiang (15% effort); PI: Wei Li, SEAK Therapeutics LLC
Completed Grants as PI
NIH/NINDS, R01NS100947, 12/01/2017 – 11/30/2023
Inflammatory regulation of neurotrophin signaling in epileptogenesis
UTHSC New Grant Support (3 projects), 10/01/2020 – 09/30/2023
NIH (NINDS), R21NS109687, 01/01/2019 – 12/31/2022
Targeting prostaglandin receptor EP2 for glioma and associated epilepsy
NIH (NINDS), R00NS082379, 07/01/2015 – 12/31/2019
Prostaglandin signaling following seizures
Brain & Behavior Research Foundation, 01/15/2014 – 01/14/2018
(Formerly the National Alliance for Research on Schizophrenia and Depression, NARSAD)
Inflammation in epilepsy-related depression
UC NI/NRC Pilot Grant, 01/01/2016 – 12/31/2016
(UC Neuroscience Institute and Neurobiology Research Center)
PGE2/EP2 signaling in Parkinson’s disease
NIH (NINDS), K99NS082379, 04/01/2013 – 03/31/2015
Prostaglandin signaling following seizures
Epilepsy Foundation, 01/01/2012 – 12/31/2012
Prostaglandin EP2 receptor in brain injury after status epilepticus